Department of Pain and Palliative Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
Int J Clin Oncol. 2024 Oct;29(10):1602-1609. doi: 10.1007/s10147-024-02574-4. Epub 2024 Jun 24.
The benefits of palliative care in patients with advanced cancer are well established. However, the effect of the skills of the palliative care team (PCT) on patient outcomes remains unclear. Our aim was to evaluate the association between hospital PCT intervention volume and patient outcomes in patients with cancer.
A retrospective cohort study was conducted using a nationwide inpatient database in Japan. Patients with cancer receiving chemotherapy and PCT intervention from 2015 to 2020 were included. The outcomes were incidence of hyperactive delirium within 30 days of admission, mortality within 30 days of admission, and decline in activities of daily living (ADL) at discharge. The exposure of interest was hospital PCT intervention volume (annual number of new PCT interventions in a hospital), which was categorized into low-, intermediate-, and high-volume groups according to tertiles. Multivariate logistic regression and restricted cubic-spline regression were conducted.
Of 29,076 patients, 1495 (5.1%), 562 (1.9%), and 3026 (10.4%) developed delirium, mortality, and decline in ADL, respectively. Compared with the low hospital PCT intervention volume group (1-103 cases/year, n = 9712), the intermediate (104-195, n = 9664) and high (196-679, n = 9700) volume groups showed significant association with lower odds ratios of 30-day delirium (odds ratio, 0.79 [95% confidence interval, 0.69-0.91] and 0.80 [0.69-0.93], respectively), 30-day mortality (0.73 [0.60-0.90] and 0.59 [0.46-0.75], respectively), and decline in ADL (0.77 [0.70-0.84] and 0.52 [0.47-0.58], respectively).
Hospital PCT intervention volume is inversely associated with the odds ratios of delirium, mortality, and decline in ADL among hospitalized patients with cancer.
姑息治疗在晚期癌症患者中的益处已得到充分证实。然而,姑息治疗团队(PCT)的技能对患者结局的影响仍不清楚。我们的目的是评估日本全国住院患者数据库中癌症患者的医院 PCT 干预量与患者结局之间的关联。
采用回顾性队列研究,纳入 2015 年至 2020 年接受化疗和 PCT 干预的癌症患者。结局指标为入院后 30 天内出现激越性谵妄的发生率、入院后 30 天内死亡率以及出院时日常生活活动能力(ADL)下降的发生率。感兴趣的暴露因素为医院 PCT 干预量(医院内每年新开展的 PCT 干预数量),根据三分位数分为低、中、高容量组。采用多变量逻辑回归和限制三次样条回归进行分析。
在 29076 例患者中,分别有 1495 例(5.1%)、562 例(1.9%)和 3026 例(10.4%)发生谵妄、死亡和 ADL 下降。与低医院 PCT 干预量组(1-103 例/年,n=9712)相比,中(104-195 例,n=9664)和高(196-679 例,n=9700)容量组入院 30 天内发生谵妄的比值比分别显著降低(比值比分别为 0.79[95%置信区间,0.69-0.91]和 0.80[0.69-0.93])、入院 30 天内死亡率(比值比分别为 0.73[0.60-0.90]和 0.59[0.46-0.75])以及 ADL 下降(比值比分别为 0.77[0.70-0.84]和 0.52[0.47-0.58])的风险降低。
医院 PCT 干预量与癌症住院患者谵妄、死亡率和 ADL 下降的比值比呈负相关。